A joint clinical review proposes a translational roadmap for using RNA biomarkers to create objective measures for neuropathic pain assessment and monitoring.
Key Takeaways
- Neuropathic pain has historically been difficult to quantify
- Company combines clinical research and engineering to develop evidence supported pain management solutions
- Ohio-based medical device innovator founded by pain management physician Amol Soin